Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis

Ninety‐seven healthy male and female subjects, 18–70 years of age, entered a randomized, double‐blind, placebo‐controlled, multicenter study conducted over a 24‐week treatment period and a 72‐week follow‐up (study week 96) period without treatment.

[1]  D. Roberts Oral therapeutic agents in fungal nail disease. , 1994, Journal of the American Academy of Dermatology.

[2]  A. Ramani,et al.  MOLDS IN ONYCHOMYCOSIS , 1993, International journal of dermatology.

[3]  B. Elewski Mechanisms of action of systemic antifungal agents. , 1993, Journal of the American Academy of Dermatology.

[4]  Hay Rj Onychomycosis. Agents of choice. , 1993 .

[5]  R. Hay Onychomycosis. Agents of choice. , 1993, Dermatologic clinics.

[6]  M. Crijns,et al.  A randomized treatment duration‐finding study of terbinafine in onychomycosis , 1992, The British journal of dermatology.